Dr. Shaf Keshavjee, Canada Invited Speaker
Lung preservation technique

Dr. Andrei Darie, Australia
Advanced donor age does not impact graft survival in a large single centre lung transplant cohort

Dr. JIAO WENYU, People's Republic of China
Developing a multidimensional immunological toolset to facilitate rejection diagnosis and mechanistic understanding of rejection, infection and chronic lung allograft dysfunction after human lung transplantation

Prof. EUN-SUK KANG, Korea
Anti-MDA5 antibody as a monitoring marker of disease recurrence after lung transplantation in rapidly progressive interstitial lung disease patients

Ambalavanan Arunachalam, United States
Donor-derived cell-free DNA is a valuable surveillance tool after single lung transplantation: Multi-center analysis

Jingyu Chen, People's Republic of China
Pediatric lung transplantation in China, 2019-2023

Dr. Hua Wenjie, People's Republic of China
Lung transplantation for pneumoconiosis in 2015-2023: Experience from two largest lung transplantation centers in China

Dr. Shui Yu, People's Republic of China
Serratus anterior plane block for analgesia after lung transplant

Prof. Gregory Snell, Australia
Pre-transplant angiotensin type 1 receptor antibodies are associated with acute kidney injury post-lung transplant

Dr. Jingzhi Xu, United States
Exploring acceptability of lung uDCD among clinical and community stakeholders in New York City

Dr. Mace Matthew Schuurmans, Switzerland
ACR detected with cryobiopsy in lung transplant recipients is not associated with elevated dd-cfDNA

Dr. Pablo E Centeno, Argentina
Prone Positioning in Potential Organ Donors. Preliminary Results. PRODON-AR Multicenter Study